Table 3. Meta-analysis of associations between rs1563828, rs11801299, rs10900598 and rs1380576 polymorphisms and cancer risk.
| Comparison | OR(95%CI) | P-value | Random/Fixed effect model | P for heterogeneity | I2 (%) |
|---|---|---|---|---|---|
| rs1563828 | |||||
| T vs. C | 0.95(0.75,1.20) | 0.658 | Fixed | 0.928 | 0.0% |
| TT+CT vs. CC | 0.96(0.70,1.32) | 0.814 | Fixed | 0.744 | 0.0% |
| TT vs. CC+CT | 0.86(0.52,1.40) | 0.536 | Fixed | 0.804 | 0.0% |
| CT vs. CC | 1.00(0.72,1.39) | 0.997 | Fixed | 0.678 | 0.0% |
| TT vs. CC | 0.86(0.51,1.45) | 0.566 | Fixed | 0.921 | 0.0% |
| rs11801299 | |||||
| AG+AA vs. GG | 0.95(0.82,1.11) | 0.529 | Fixed | 0.399 | 0.0% |
| rs10900598 | |||||
| GT+TT vs. GG | 0.91(0.78,1.08) | 0.288 | Fixed | 0.483 | 0.0% |
| rs1380576 | |||||
| CG+GG vs. CC | 1.08(0.95,1.22) | 0.227 | Fixed | 0.785 | 0.0% |
*Bold values are statistically significant (P < 0.05).